Zumiez Soars on September Sales and Guidance

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Zumiez Soars on September Sales and Guidance

© Thinkstock

Zumiez, Inc. (NASDAQ: ZUMZ) shares are making a run on Thursday after the company reported its sales results for September 2016. At the same time, the company also upped the stakes when it increased guidance for the fiscal third-quarter.

The company announced that total net sales for the five-week period ended October 1, 2016, increased 11.5% to $75.0 million, compared to $67.3 million for the five-week period ended October 3, 2015. The Company’s comparable sales increased 6.3% for the five-week period compared to a comparable sales decrease of 1.8% in the year ago period.

Based primarily on higher than planned sales quarter-to-date, Zumiez is also raising its guidance and now expects fiscal 2016 third quarter net sales to be in the range of $216 million to $217 million and net income per diluted share of roughly $0.29 to $0.30. This guidance is now predicated on a comparable sales increase of approximately 2% for the third quarter.

[nativounit]

The previously issued guidance called for net sales in the range of $209 million to $213 million and net income per diluted share of approximately $0.21 to $0.26.

A few analysts weighed in on Zumiez on Thursday:

  • Stifel has a Hold rating with an $18 price target.
  • Wedbush has a Neutral rating with an $18 price target.
  • William Blair upgraded to an Outperform rating.
  • Mizuho has a Neutral rating with a $19 price target.

Excluding Thursday’s move, Zumiez has outperformed the broad markets with the stock up nearly 21% year to date. Over the past 52-weeks the stock is up only 12%.

Shares of Zumiez were last trading up 18% at $21.61, with a consensus analyst price target of $16.27 and a 52-week trading range of $11.53 to $22.14.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618